Suscribirse

Neutrophil extracellular traps induced by pro-inflammatory cytokines enhance procoagulant activity in NASH patients - 12/01/22

Doi : 10.1016/j.clinre.2021.101697 
Jingwen Du a, Jinming Zhang b, Xiaojing Chen a, Shuoqi Zhang c, Cong Zhang a, Huan Liu a, Yueyue Li a, Mengdi Li a, Xiaoming Wu a, Mengqi Xiang a, Chengyue Wang a, Langjiao Liu a, Chunli Wang a, Shaohong Fang d, , Jialan Shi a, e, f,
a Department of Hematology, The First Affiliated Hospital, Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang, China 
b Department of Hematology and Rheumatology, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China 
c Department of Neurology, The Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China 
d The Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin, Heilongjiang, China 
e Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, MA, USA 
f Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1400 VFW Parkway, West Roxbury, Boston, MA 02132, USA 

Corresponding authors.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

páginas 9
Iconografías 3
Vídeos 0
Otros 0

Highlights

Our objectives were to study the NETs formation in NASH patients and to evaluate its procoagulant activity.
Inflammatory cytokines promote NETs formation leading to procoagulant activity in NASH patients.
NETs derived from NASH could dramatically shorten coagulation time and markedly increased the fibrin formation and TAT complexes.
NASH-NETs convert HUVECs to procoagulant and pro-inflammatory phenotypes.
Our findings demonstrated that NETs might play a important role in procoagulant activity in NASH, providing an ideal therapeutic strategy for attenuating inflammation and preventing the pathological hypercoagulable state of NASH patients.

El texto completo de este artículo está disponible en PDF.

Summary

Background

Nonalcoholic steatohepatitis (NASH) patients are at a high risk of developing venous thromboembolism, with a high rate of morbidity and mortality. The role of neutrophil extracellular traps (NETs) in procoagulant activity (PCA) in patients with NASH remains unclear. Our study aimed to investigate the formation of NETs in NASH patients stimulated by specific pro-inflammatory factors. Moreover, we evaluated the pivotal role of NETs in the induction of hypercoagulability in NASH and the interaction between NETs and endothelial injury.

Method

The levels of the NETs biomarkers were evaluated in the plasma samples of 27 NASH patients and 18 healthy subjects. The formation of NETs was visualized using immunofluorescence microscopy. The PCA of the NETs was assessed using coagulation time, purified coagulation complex, and fibrin formation assays. Confocal microscopy was further used to evaluate the interactions between the NETs and HUVECs.

Results

The levels of NETs markers in the plasma of NASH patients were significantly higher than healthy controls. NETs derived from NASH enhanced thrombin and fibrin formation and significantly reduced CT (p<0.05). The mixture of IL-6 and TNF-α triggered the NETs release in the plasma rather than them alone. Additionally, the NETs exerted cytotoxic effects on the endothelial cells, converting them to a procoagulant and pro-inflammatory phenotype, and DNase I could reverse these effects.

Conclusion

Our results revealed the primary role of NETs in promoting the hypercoagulable state in NASH patients. Methods that prevent the formation of NETs may be a novel approach for the prevention and treatment of NASH.

El texto completo de este artículo está disponible en PDF.

Abbreviations : NASH, NETs, PCA, NAFLD, CVD, VTE, CT, BMI, AST, ALT, TBil, TC, TG, HDL, LDL, PT, aPTT, PAI-1

Keywords : neutrophil extracellular traps, procoagulant activity, NASH, inflammatory factors


Esquema


© 2021  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 46 - N° 1

Artículo 101697- janvier 2022 Regresar al número
Artículo precedente Artículo precedente
  • Comparison of Interferon-α-based therapy and nucleos(t)ide analogs in preventing adverse outcomes in patients with chronic hepatitis B
  • Qian-Guo Mao, Hui-Qing Liang, Ya-Lin Yin, Jin-Mo Tang, Jia-En Yang, Chun-Cheng Wu, Yue Chen, Man-Ying Zhang, Yao-Yu Liu, Xiao-Ting Zheng, Lin-Yi Zhuang, Shao-Dong Chen
| Artículo siguiente Artículo siguiente
  • Inhibition of USP11 sensitizes gastric cancer to chemotherapy via suppressing RhoA and Ras-mediated signaling pathways
  • Hongfang Liu, Mei Liu, Bin He, Qinghuan Li

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.